publication venue for Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: the Axtell regimen.. 23:785-790. 2012 Epidermal growth factor receptor as a biomarker for cervical cancer.. 22:2166-2178. 2011